Showing 1,523 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

Trump has big plans to fix drug prices. Here’s your reality check.

Editor's pick
STAT
1 February 2017
Pharmaceutical industry

Trump wants to blow up the FDA. The drug industry? Not so much.

Editor's pick
STAT
1 February 2017
Access to healthcare

English High Court refers Truvada SPC case to EU Court of Justice

Editor's pick
Life Sciences Intellectual Property Review (free subscription needed to read)
27 January 2017
Drug-resistant TB

Public Health Groups Welcome Johns Hopkins University and Medicines Patent Pool Agreement for Development of Promising New TB Drug

Editor's pick
MSF Access Campaign
26 January 2017
Pharmaceutical industry

From Twitter To Treatment Guidelines, Industry Influence Permeates Medicine

Editor's pick
NPR
18 January 2017
Hepatitis C treatment

Japan: Hepatitis C drug fakes found in Nara drugstore chain

Editor's pick
The Japan Times
18 January 2017
Pharmaceutical industry

The U.S. Government Should Buy Gilead For $156 Billion To Save Money On Hepatitis C

Editor's pick
Forbes
17 January 2017
PrEP

The ‘final nail in the coffin’ for Aids?

Editor's pick
Financial Times
5 January 2017
Changing treatment

GlaxoSmithKline’s New Drug Challenges HIV Treatment Orthodoxy

Editor's pick
Wall Street Journal
20 December 2016
Pharmaceutical industry

Gilead’s Patent Loss to Merck Started With a Broken Friendship

Editor's pick
Bloomberg
19 December 2016
Pharmaceutical industry

Merck wins $2.54 billion in hepatitis C drug trial against Gilead

Editor's pick
Reuters
16 December 2016
Clinical trials

The FDA Should Approve Drugs Based on Evidence, Not Emotions

Editor's pick
Slate
15 December 2016
Government, leadership & policy

Winners and Losers in the 21st Century Cures Act

Editor's pick
Poz
15 December 2016
Pharmaceutical industry

Trump is considering a dangerous radical to lead FDA. Here’s why that’s bad news.

Editor's pick
STAT
12 December 2016
PrEP

MP calls for PrEP manufacturer to submit to Scottish regulator

Editor's pick
Pink News
2 December 2016
Pharmaceutical industry

Gilead's HIV Business Is More Cash Cow Than Shining Star

Editor's pick
Seeking Alpha
28 November 2016
Clinical trials

Could the FDA be dismantled under Trump?

Editor's pick
STAT
22 November 2016
New & experimental HIV treatments

ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen

Editor's pick
ViiV press release
21 November 2016
Pharmaceutical industry

Exposed: Southern African trio 'sold expired ARVs' in Europe at a 4 000% markup

Editor's pick
Bhekisisa
17 November 2016
Activism & civil society

Community demand for temporary halt to Gilead DISCOVER study

Editor's pick
HIV Prevention Justice Alliance
17 November 2016
Activism & civil society

Why Are HIV Groups Charging Gilead With Bad Behavior in New PrEP Trial?

Editor's pick
The Body
17 November 2016
PrEP

Statement on DISCOVER Study of F/TAF for PrEP

Editor's pick
Gilead Sciences
16 November 2016
Pharmaceutical industry

‘Hard’ Brexit would delay access to new drugs, warns report

Editor's pick
Pharma Times
9 November 2016
Access to healthcare

These researchers think they have a solution to the global crisis in drug prices

Editor's pick
Washington Post
8 November 2016